Sunshine Noah: BTP4327 Clinical Trial Application Approved

Sunshine Nuohuo Announcement: The company and its subsidiary, Jiangsu Nuohuo Becton New Drug Research and Development Co., Ltd., have received the “Drug Clinical Trial Approval Notice” issued by the National Medical Products Administration. The clinical trial application for the company’s ongoing project BTP4327 has been approved. BTP4327 is a Class 2 chemical drug, an improved new drug, intended to treat hypertension by lowering blood pressure. It is for patients whose blood pressure cannot be adequately controlled with monotherapy.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin